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Abstract 
 
The fibroblast, a connective tissue cell, secretes or breaks down the extracellular matrix (ECM) 
via chemical signaling that alters gene expression. This function is necessary in cardiac 
fibroblasts to maintain the structure and function of the heart, but when an injury occurs and 
fibroblasts are active for remodeling, these changes may become maladaptive, leading to cardiac 
fibrosis and reduced cardiac function. Signal transducer and activator of transcription 3 (STAT3) 
is a transcription factor that regulates genes involved in cell proliferation, survival, and synthesis 
of ECM components in fibroblasts. Preliminary studies from our group identified a novel 
complex involving the cytoskeletal protein βIV-spectrin and STAT3, important for normal 
subcellular distribution and activity of STAT3 in the heart. Loss of βIV-spectrin function 
promotes STAT3 mislocalization, changes in gene expression, and maladaptive cardiac 
remodeling with relevance to animal models of heart failure and human patients. While previous 
work has utilized a cardiomyocyte specific βIV-spectrin knockout mouse to examine the role of 
spectrin/STAT3 complex in cardiomyocytes, the question remains whether this complex plays a 
broader role in non-myocytes (e.g. fibroblasts). Furthermore, questions remain about the 
mechanism by which STAT3 mislocalization results in altered gene transcription in any cell 
(myocyte or otherwise). The overall goal of this study is to better understand the relationship 
between changes in βIV-spectrin function and altered gene transcription in the heart. This study 
tests the hypothesis that βIV-spectrin associates with STAT3 in cardiac fibroblasts to directly 
regulate gene expression of proteins related to stress signaling and cardiac remodeling. The 
following mouse models were used for this study: wild type and qv4J (lacks spectrin/STAT3 
interaction). First, confocal microscopy was used to study the distribution of STAT3 in 
fibroblasts in the presence and absence of spectrin/STAT3 interaction. Next, echocardiography 
was used to assess cardiac function and heart sections were analyzed for fibrosis. Finally, 
quantitative PCR (qPCR) was used to quantify the expression of important STAT3 regulated 
genes in the fibroblasts. Results show STAT3 localization to the nucleus, decreased ejection 
fraction, increase in left ventricular (LV) chamber diameter, LV wall thinning, increased fibrosis, 
and increased mRNA expression of COL14a in the qv4J mouse model compared to wild type. 
The mechanisms seen in cardiomyocytes and fibroblasts are potential targets for reducing or 
inhibiting remodeling effects.   
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 1 
Introduction 
 
From 2009 to 2012, approximately 5.7 million Americans 20 years or older had heart failure 
(HF)1. The prevalence of HF is expected to increase by 46% from 2012 to 2030, which means 
more than 8 million people who are 18 years or older will have HF1. HF is a complex 
multifactorial syndrome characterized by maladaptive structural remodeling and compromised 
function of the heart. One cell type that plays an important role in the remodeling process is the 
fibroblast. Fibroblasts are flat, spindle-shaped, connective tissue cells that can be found in 
vertebrate organisms and are able to secrete or breakdown the extracellular matrix (ECM) 
depending on chemical signals, like cytokines and growth factors2. These signals can alter gene 
expression in fibroblasts and control the movement of cells to injured regions for healing and 
scar formation2. Fibroblasts convert to their activated form, myofibroblasts, to perform these 
functions3. For remodeling, myofibroblasts will secrete more ECM, which promotes cardiac 
fibrosis3. Cardiac fibrosis can lead to adverse effects, like cardiomyocyte hypertrophy and cell 
death3. 
 
 
Figure 1. STAT3 associates with βIV-spectrin in cardiomyocytes. (A) βIV-spectrin targets STAT3 through 
direct protein-protein interaction and (B) the loss of βIV-spectrin results in cellular redistribution of STAT3, 
changes in gene expression, increased fibrosis, and decreased heart function5. 
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Signal transducer and activator of transcription 3 (STAT3) acts as a coordinator to balance 
protective and detrimental mechanisms of stress signaling in cardiomyocytes4. STAT3 is a 
transcription factor that regulates genes that code for proteins4. Specifically to fibroblasts, 
STAT3 contributes to cell proliferation, survival, and synthesis of ECM components4. 
Preliminary studies from our group have shown that STAT3 associates with βIV-spectrin, a 
cytoskeletal protein, which controls the distribution and activity of STAT3 in cardiomyocytes5. 
βIV-spectrin is primarily found at the cardiomyocyte intercalated disc, a specialized membrane 
domain important for cell-to-cell electrical and mechanical communication, and plays an 
important role in organizing local signaling domains for regulation of ion channels and cell 
membrane excitability in the heart5,6,7. Preliminary studies show that βIV-spectrin targets STAT3 
to the intercalated disc membrane through direct protein-protein interaction and that loss of  
βIV-spectrin results in cellular redistribution of STAT3, changes in gene expression, increased 
fibrosis, and decreased heart function (Figure 1)5. Furthermore, downregulation of βIV-spectrin 
and STAT3 redistribution was observed in mouse models of heart failure (transaortic 
constriction) and human heart failure patients5. Previous studies have shown that βIV-spectrin 
 
Figure 2. Long-term hyperphosphorylating conditions promote loss of βIV-spectrin. Representative 
immunoblots (A) for βIV-spectrin (actin used as loading control) for WT and qv3J (lacks βIV-spectrin/CaMKII 
interaction) subjected to prolonged pacing (2, 6, 12 hrs, 2 Hz) in the presence of isoproterenol and okadaic acid to 
simulate long-term (hyperphosphorylating) conditions. Subset of WT cells incubated with CaMKII inhibitor KN-
93 (10 m) during pacing. (B) Significant decrease in βIV-spectrin expression at 6 and 12 hrs relative to baseline 
(2 hrs). *P<0.05 vs. WT, N=3 independent preparations per genotype/condition. 
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targets the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) to ion channel 
substrates at the cardiomyocyte intercalated disc6. Hyperphosphorylating conditions to simulate 
long-term stress conditions promote CaMKII mediated degradation of βIV-spectrin which may be 
prevented by global (CaMKII inhibitor, KN-93) or targeted (intercalated disc subpopulation, 
qv3J) inhibition of CaMKII (Figure 2) 5. 
 
Although it is known how STAT3 is distributed throughout cardiomyocytes via the 
spectrin/STAT3 association, and it is known that STAT3 alters gene expression in the nucleus, 
this study will directly link the spectrin/STAT3 association to gene expression. This study will 
test the hypothesis that βIV-spectrin associates with STAT3 in cardiac fibroblasts to directly 
regulate gene expression of proteins related to stress signaling and cardiac remodeling by 
applying mechanisms seen in cardiomyocytes to fibroblasts, which are potential targets for 
reducing or inhibiting remodeling effects due to their pathology. 
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Methodology 
 
Animals: qv4J and wild type (WT) animals were obtained from Jackson Laboratories (Figure 3)8. 
All experiments were performed in 8-week-old male mice. Animals were euthanized using CO2 
and cervical dislocation followed by collection of tissue or cell isolation. 
 
Isolation of Cardiac Fibroblasts: The following protocol was adapted from a previously used 
method9. Hearts were isolated from WT and qv4J animals. The ventricles were excised and 
thoroughly minced with sterile fine scissors and digested in Ham’s F-10 medium and Trypsin-
EDTA (0.25%) at 37 C for 30 min. During this incubation, the digesting tissue was triturated for 
a minute with a sterile serological pipette every 15 min. After incubation, a mixture of Ham’s F-
10 medium, collagenase type 2 (200 mg/ml), and soybean trypsin inhibitor (200 mg/ml) was 
added to the digesting tissue and incubated at 37 C for 50 min. After digestion, the suspension 
of digested tissue was collected into a tube and debris was eliminated by two serial 
centrifugations at 2000 RPM for 5 min. Pellets were resuspended in media consisting of DMEM 
(1X), L-glutamine (200 mM), antibiotic-antimycotic (100X), and fetal bovine serum (10%). 
Cells were seeded onto a 12-well plate. Over the course of 4-6 days, media was replaced, and 
right before cells reached confluency, they were passaged into a 6-well plate, where they were 
allowed to reach confluency.  
 
Confocal Microscopy: Cardiac fibroblast cells from WT and qv4J were blocked in PBS 
containing Triton X-100 (0.15%), normal goat serum (3%), and BSA (1%). The cells were 
incubated in primary antibody overnight at 4 C. Cells were then washed with PBS and then 
incubated in secondary antibody for 2 hrs at room temperature. The cells were mounted using 
Vectashield with DAPI and coverslips. Confocal microscopy images were collected on a Zeiss 
 
 
Figure 3. βIV-spectrin structure in WT and qv4J animals. qv4J animals express mutant βIV-spectrin allele 
with pre-mature stop codon prior to ankyrin-binding site. Spectrin repeat 15 contains a putative proline-rich 
STAT3-binding domain (*). 
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780 confocal microscope [Objective W Plan Apochromat 40 x/1.0 DID (Zeiss), pinhole equals 
1.0 Airy Disc] with Carl Zeiss Imaging software. 
 
Echocardiography: Echocardiography images of the left ventricle were collected on WT and 
qv4J mice using the Vevo 2100 (VisualSonics) with the MS-400 transducer. Animals were 
anesthetized and secured in the supine position. The heart was first imaged in the long-axis view, 
which was used to determine the position of the heart and serve as a reference point to obtain the 
short-axis view. Short-axis M-mode was used to assess cardiac function. M-mode images were 
used to calculate heart rate (HR), LV inner chamber diameter in diastole (LVID, d), ejection 
fraction (EF), fractional shortening (FS), LV anterior wall thickness in diastole (LVAW, d), and 
LV posterior wall thickness in diastole (LVPW, d). 
 
Fibrosis: Left ventricular tissue from WT and qv4J animals were obtained and stained using 
Masson’s Trichrome method. Custom software was used to calculate the percentage of fibrosis 
of interstitial and epicardial regions. 
 
Quantitative PCR: The following protocol was adapted from a previously used method7. Total 
RNA from WT and qv4J cardiac fibroblasts was extracted with TRIzol Reagent plus RNeasy 
column purification (Qiagen) following manufacturer’s instructions. 500 ng of total RNA treated 
with DNase I was used for the first-strand complementary DNA synthesis using SuperScript III 
reverse transcriptase VILO cDNA Synthesis Kit (Invitrogen). qPCR reactions were performed in 
triplicates on cDNA samples in 96-well optical plates with SYBR Green Assay (Thermo 
Fisher) and SYBR Green Master Mix (Thermo Fisher) to maximize PCR precision and 
uniformity. PCR was performed at 95 C for 3 min, 40 cycles of 95 C for 15 s and 60 C for 1 
min on Applied Biosystems 7900HT Fast Real-Time PCR System or StepOnePlus Real-Time 
PCR System (Life Technologies). PCR data were analyzed using the relative standard curve 
method and the 2 delta Ct method was used to calculate fold changes in relative gene expression. 
PCR products were confirmed by the melt-curve analysis, amplicon length, and DNA 
sequencing. RPL-7 levels were used as a normalization control. 
 
Statistics: Sigmaplot 13.0 was used for statistical analyses. P-values were determined for 
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comparison using Student’s t-test. A P-value of <0.05 was considered statistically significant. 
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Results 
 
STAT3 localization is altered in qv4J cardiac fibroblasts lacking spectrin/STAT3 interaction 
Preliminary studies have shown that the loss of βIV-spectrin results in altered subcellular 
localization of STAT3 in cardiac myocytes5. In order to test whether IV-spectrin serves a similar 
function in cardiac fibroblasts, the heart was isolated from a qv4J animal and processed to grow 
fibroblasts. Confocal images show increased localization of STAT3 to the nucleus in the qv4J 
fibroblast compared to that of the WT cardiac fibroblast (Figure 4). These results indicate that 
the loss of βIV-spectrin in cardiac fibroblasts alters the distribution of STAT3 due to the loss of 
spectrin/STAT3 interaction in the qv4J cardiac fibroblast. 
Cardiac function is compromised in qv4J mice lacking spectrin/STAT3 interaction 
Preliminary studies have shown that the loss of βIV-spectrin results in decreased heart function5. 
In order to verify this mechanism specifically in qv4J animals, echocardiography was used to 
assess cardiac function. qv4J animals demonstrated symptoms of heart failure, including LV 
dilation and decreased ejection fraction as well as LV wall thinning compared to WT at baseline 
 
Figure 4. Altered STAT3 localization in qv4J cardiac fibroblasts lacking spectrin/STAT3 interaction. 
Representative confocal microscopy images of permeabilized adult WT and qv4J CFs immunostained for 
STAT3 (green), phalloidin (purple), and DAPI (blue). Scale bar = 8μm. 
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conditions (Figure 5). Consistent with previous findings, these results show that the lack of 
spectrin/STAT3 interaction in the qv4J animal contributes to decreased cardiac function. 
 
Fibrosis increases in qv4J mice lacking spectrin/STAT3 interaction 
Preliminary studies have shown that the loss of βIV-spectrin results in increased fibrosis5. 
Analysis of interstitial and epicardial regions of heart sections using a custom software was used 
 
Figure 5. Compromised cardiac function in qv4J mice lacking spectrin/STAT3 interaction. Representative 
echocardiograms (A) and summary data (B) from 8-week old WT and qv4J mouse at baseline. qv4J mice show 
decreased ejection fraction, increase in left ventricular (LV) chamber diameter, and LV wall thinning compared 
to WT at baseline conditions. *P<0.05 in qv4J vs. WT, N=5. 
 
 
Figure 6. Increased fibrosis in qv4J mice lacking spectrin/STAT3 interaction. (A) Representative Masson’s 
Trichrome stained heart sections (collagen labeled blue). (B) Summary data showing fibrosis as percentage of 
tissue area from WT and qv4J at baseline conditions. N=2 independent preparations. 18 fields analyzed per 
preparation.  
l 
 9 
to verify this mechanism specifically in qv4J animals. Results showed increased fibrosis in qv4J 
hearts, both in the interstitial and epicardial regions, compared to that of WT hearts (Figure 6). 
These results suggest that the lack of spectrin/STAT3 interaction in the qv4J animal contributes to 
maladaptive cardiac remodeling, which may then be leading to decreased heart function. 
 
Gene expression is altered in qv4J cardiac fibroblasts lacking spectrin/STAT3 interaction 
To determine whether βIV-spectrin dysfunction was associated with altered gene expression in 
cardiac fibroblasts, quantitative PCR (qPCR) was performed on WT and qv4J cardiac fibroblast 
populations. qPCR confirmed the expression of SPTBN4 in WT cardiac fibroblasts and the lack 
of expression of SPTBN4 in qv4J cardiac fibroblasts. mRNA expression of COL14a in qv4J 
cardiac fibroblasts was found to be greater than that of WT cardiomyocytes. This is consistent 
with the idea that fibroblasts play a direct role in cardiac remodeling through the secretion of the 
ECM in response to chemical signaling. qv4J cardiac fibroblasts show higher expression of 
COL14a and lower expression of SPTBN4 compared to those of WT cardiac fibroblasts. These 
results support that gene expression is altered in qv4J cardiac fibroblasts because they lack 
spectrin/STAT3 interaction. 
 
 
 
Figure 7. Altered gene expression in qv4J cardiac fibroblasts. qPCR shows SPTBN4 mRNA expression in 
WT CFs with increased COL14a mRNA in CFs compared to cardiomyocytes. qv4J CFs show higher COL14a 
and lower SPTBN4 mRNA expression compared to WT CFs. RPL-7 was used a control gene.  
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Conclusion 
 
Preliminary studies from our group identified a complex involving the cytoskeletal protein βIV-
spectrin and STAT3, important for normal subcellular distribution and activity of STAT3 in the 
heart5. Loss of βIV-spectrin function promotes STAT3 mislocalization, changes in gene 
expression, and maladaptive cardiac remodeling with relevance to animal models of heart failure 
and human patients5. The overall goal of this study was to better understand the relationship 
between changes in βIV-spectrin function and altered gene transcription in the heart. This study 
tested the hypothesis that βIV-spectrin associates with STAT3 in cardiac fibroblasts to directly 
regulate gene expression of proteins related to stress signaling and cardiac remodeling. The 
results from this study show that spectrin/STAT3 complex is present in cardiac fibroblasts, and 
the loss of spectrin/STAT3 interaction leads to the localization of STAT3 to the nucleus (Figure 
4). Results suggest that the spectrin/STAT3 complex may play a role in regulating cardiac 
fibrosis (Figures 5 and 6). It was also shown that βIV-spectrin associates with STAT3 in cardiac 
fibroblasts to regulate gene expression of proteins related to stress signaling and cardiac 
remodeling (Figure 7). These mechanisms seen in cardiomyocytes and cardiac fibroblasts are 
potential targets for reducing or inhibiting remodeling effects. Inhibiting the activation of STAT3 
in cardiomyocytes and/or cardiac fibroblasts may decrease cardiac fibrosis, thereby reducing 
adverse effects such as hypertrophy and cell death that contribute to heart failure. 
 
For future work, it will be important to study the functional activity of STAT3 in fibroblasts as 
well as quantify the presence of STAT3 in cytoplasmic and nucleic fractions of fibroblasts. It 
will also be important to show that the changes in STAT3 distribution and activity in cardiac 
fibroblasts are due to its direct interaction with βIV-spectrin through rescue experiments. The 
potential for using spectrin/STAT3 as a therapeutic target can be studied through treatments with 
STAT3 inhibitor. Finally, obtaining a mouse model with a cardiac fibroblast-specific βIV-spectrin 
knockout will be important for distinguishing the effects of the spectrin/STAT3 interactions in 
cardiac fibroblasts from those of cardiomyocytes. 
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